†Incidences of the adverse reactions have been calculated for all the individual studies. (min%–max%) are the lowest and highest observed incidence of an adverse reaction observed in the group of studies included.
‡ Transdermal application only.
§ One study administered DMSO through intraarticular injection [ 38].
¶ DMSO was administered intravenously in all studies.